Roles and Clinical Applications of OPG and TRAIL as Biomarkers in Cardiovascular Disease - Test2 - elhamkhani - TriplyDB

Roles and Clinical Applications of OPG and TRAIL as Biomarkers in Cardiovascular Disease

Roles and Clinical Applications of OPG and TRAIL as Biomarkers in Cardiovascular Disease

http://www.wikidata.org/entity/Q26747224

about

Circulating osteoprotegerin is associated with chronic kidney disease in hypertensive patients Dyslipidemia and Diabetes Increase the OPG/TRAIL Ratio in the Cardiovascular System.Osteoprotegerin concentration and risk of cardiovascular outcomes in nine general population studies: Literature-based meta-analysis involving 26,442 participants.Elevated serum osteoprotegerin may predict peripheral arterial disease after kidney transplantation: a single-center prospective cross-sectional study in Taiwan.Low Circulating TRAIL Levels Are Associated with Increase of Resistin and Lipocalin-2/ngal Adipokines in Postmenopausal Women.Unbalanced Vitreous Levels of Osteoprotegerin, RANKL, RANK, and TRAIL in Proliferative Diabetic Retinopathy.Investigation of OPG/RANK/RANKL Genes as a Genetic Marker for Cardiac abnormalities in Thalassemia Major Patients.

P2860

Q33882341-53E10A2B-796F-4563-809C-7932A0A73FD6 Q40041063-4E6BAA64-9C69-493F-B172-70305DD98B62 Q41513500-46654F02-7AC7-4DA9-98D5-846DB82075BC Q42278602-71729FF5-A028-46C9-8FB2-5AD6071346D8 Q43379345-E1C99C60-5DCE-426E-AD28-EB9BE430AC4D Q50071959-83BE1CCA-7471-4FBE-9222-451248F5D131 Q51119015-7766C8D5-DDAE-4D78-9F09-AA11AC7EA1BC

P2860

Roles and Clinical Applications of OPG and TRAIL as Biomarkers in Cardiovascular Disease

http://www.wikidata.org/entity/Q26747224

description

2016 nî lūn-bûn

@nan

2016 թուականի Ապրիլին հրատարակուած գիտական յօդուած

@hyw

2016 թվականի ապրիլին հրատարակված գիտական հոդված

@hy

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

name

Roles and Clinical Applications of OPG and TRAIL as Biomarkers in Cardiovascular Disease

@ast

Roles and Clinical Applications of OPG and TRAIL as Biomarkers in Cardiovascular Disease

@en

Roles and Clinical Applications of OPG and TRAIL as Biomarkers in Cardiovascular Disease

@nl

type

label

Roles and Clinical Applications of OPG and TRAIL as Biomarkers in Cardiovascular Disease

@ast

Roles and Clinical Applications of OPG and TRAIL as Biomarkers in Cardiovascular Disease

@en

Roles and Clinical Applications of OPG and TRAIL as Biomarkers in Cardiovascular Disease

@nl

prefLabel

Roles and Clinical Applications of OPG and TRAIL as Biomarkers in Cardiovascular Disease

@ast

Roles and Clinical Applications of OPG and TRAIL as Biomarkers in Cardiovascular Disease

@en

Roles and Clinical Applications of OPG and TRAIL as Biomarkers in Cardiovascular Disease

@nl

P1433

Q26747224-36D863F7-2643-47C8-93A4-0FF27EDCBACC

P1476

Q26747224-BD1DC6D8-CA6B-4E4F-B6A3-AA5F480AD887

P2093

Q26747224-40F311B5-C7F1-4C8A-9335-2F9B2BCA4028

Q26747224-DBD070A6-EED0-4699-9D6C-F96E1CDDB51E

P275

Q26747224-73E0F161-962E-4B06-9F56-0E317A9DFE07

P2860

Q26747224-00E0206F-0A31-4489-A101-7D395D977C3B

Q26747224-014B56DB-57CE-4F9F-825E-1BDF17AFDA7E

Q26747224-01A747BC-4B3A-4A7F-90CC-AA168676D583

Q26747224-091D3804-6F82-442C-9D47-796B62E61CD0

Q26747224-097114E5-B506-417B-B569-C1F274F952A8

Q26747224-0C66E012-05BE-4CFC-9973-CB5D9E970A67

Q26747224-12CE966C-2D3B-48B5-B135-1EC364CDA315

Q26747224-1543C110-CB37-4DBE-90EA-EBA4FE15F8E0

Q26747224-1BEAE9EA-586E-40ED-93B6-6EA14C0A7B72

Q26747224-1C59615F-5365-4A72-9C97-694A8B08FB11

P304

Q26747224-00623861-0120-42E5-B6F1-A5BDEFE67735

P31

Q26747224-C0B003B1-E155-4BBF-A1A9-16BB51CB4D85

Q26747224-E33E8A5E-F25F-4FB9-8D2D-17C276ADBEC8

P3181

Q26747224-64BD3430-7E36-4710-AE5D-82CC59ACEC87

P356

Q26747224-3821D162-ED9E-4DD0-9292-C0E668AF34A3

P407

Q26747224-A7EB8A28-B236-4A55-A002-EE9305418219

P478

Q26747224-31F304E7-0762-45CA-85E4-0B919E4F1137

P50

Q26747224-A4719F51-835F-4A45-8A25-D7BC0EAEA33F

Q26747224-DECD4DFA-93CC-4ED6-BE2F-7AAD4CFC369A

P5008

Q26747224-95FE6DCD-101D-4B46-B048-8C9C9B535B4E

P577

Q26747224-20C95769-9FCB-4993-8DF5-25560E30141A

P698

Q26747224-60198B3C-1C10-4FBD-ACB2-2BA8AE24B399

P921

Q26747224-1DDE3FA2-68DD-463B-8F5B-572B01651615

Q26747224-51C135AC-7BCC-4D28-A118-3119836DFA51

Q26747224-715ADFDF-B24B-47A8-A8D3-E0E53D0E2EA5

Q26747224-7A3367C9-846A-4ACD-88BB-8E8686459CDE

Q26747224-92381AE9-6934-4C73-BC42-CE1E184F5D7C

P932

Q26747224-D97A07D3-3B19-420C-B790-2D675825581A

P3181

P356

P1433

BioMed Research International

P1476

Roles and Clinical Applications of OPG and TRAIL as Biomarkers in Cardiovascular Disease

@en

P2093

Bruno Fabris

http://www.w3.org/2001/XMLSchema#string

Fleur Bossi

http://www.w3.org/2001/XMLSchema#string

P275

Creative Commons Attribution 4.0 International

P2860

The receptor for the cytotoxic ligand TRAIL

Osteoprotegerin: a novel secreted protein involved in the regulation of bone density

Cloning and characterization of TRAIL-R3, a novel member of the emerging TRAIL receptor family

Identification and characterization of a new member of the TNF family that induces apoptosis

The novel receptor TRAIL-R4 induces NF-kappaB and protects against TRAIL-mediated apoptosis, yet retains an incomplete death domain

Characterization of a novel TNF-like ligand and recently described TNF ligand and TNF receptor superfamily genes and their constitutive and inducible expression in hematopoietic and non-hematopoietic cells

Isolation of a novel cytokine from human fibroblasts that specifically inhibits osteoclastogenesis

osteoprotegerin-deficient mice develop early onset osteoporosis and arterial calcification

Biomarkers of the osteoprotegerin pathway: clinical correlates, subclinical disease, incident cardiovascular disease, and mortality

Tumor necrosis factor receptor family member RANK mediates osteoclast differentiation and activation induced by osteoprotegerin ligand

P304

1752854

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

2156993

http://www.w3.org/2001/XMLSchema#string

P356

10.1155/2016/1752854

http://www.w3.org/2001/XMLSchema#string

P407

P478

2016

http://www.w3.org/2001/XMLSchema#string

P50

Stella Bernardi

Barbara Toffoli

P5008

P577

2016-04-21T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27200369

http://www.w3.org/2001/XMLSchema#string

P921

cell surface receptor

cardiovascular disease

membrane proteins

P932

4856888

http://www.w3.org/2001/XMLSchema#string